login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
AQUESTIVE THERAPEUTICS INC (AQST) Stock News
USA
-
Nasdaq
- NASDAQ:AQST -
US03843E1047
-
Common Stock
6.19
USD
-0.03 (-0.48%)
Last: 11/28/2025, 8:12:57 PM
6.07
USD
-0.12 (-1.94%)
Pre-Market:
12/1/2025, 8:48:48 AM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
AQST Latest News, Press Relases and Analysis
All
Press Releases
7 days ago - By: Aquestive Therapeutics, Inc.
Aquestive Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference
19 days ago - By: Benzinga
- Mentions:
APH
JOBY
Jim Cramer: Joby Is 'Losing Too Much Money'
26 days ago - By: Zacks Investment Research
Here's What Key Metrics Tell Us About Aquestive Therapeutics (AQST) Q3 Earnings
26 days ago - By: Zacks Investment Research
- Mentions:
MGX
Aquestive Therapeutics (AQST) Reports Q3 Loss, Lags Revenue Estimates
26 days ago - By: Aquestive Therapeutics, Inc.
Aquestive Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
a month ago - By: Benzinga
- Mentions:
TECH
INSE
GEF
SKYT
...
Earnings Scheduled For November 5, 2025
2 months ago - By: Stocktwits
Aquestive Stock Jumps After-Hours As CEO Sees $1B ‘Blockbuster’ Potential For Oral Allergy Film — Retail Sees Stock As Buyout Candidate
3 months ago - By: Stocktwits
- Mentions:
IWMW
VTWG
FDA Says No Advisory Committee Meeting Needed For Aquestive’s Oral Epinephrine Film
26 days ago - By: Aquestive Therapeutics, Inc.
Aquestive Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
a month ago - By: Aquestive Therapeutics, Inc.
- Mentions:
TLSA
Aquestive Therapeutics Announces Leadership Expansion to Support Growth
a month ago - By: Aquestive Therapeutics, Inc.
Aquestive Therapeutics to Participate in a Fireside Chat Hosted by Piper Sandler
4 months ago - By: Stocktwits
- Mentions:
IWMW
VTWG
Aquestive Therapeutics Stock Is Rising Pre-Market – Its $75M Funding Agreement Draws Divided Opinions From Retail
a month ago - By: Zacks Investment Research
- Mentions:
DBVT
Is DBV Technologies (DBVT) Stock Outpacing Its Medical Peers This Year?
a month ago - By: Aquestive Therapeutics, Inc.
Aquestive Therapeutics to Attend 2025 ACAAI Annual Meeting
a month ago - By: Aquestive Therapeutics, Inc.
Aquestive Therapeutics to Report Third Quarter 2025 Financial Results and Recent Business Highlights on November 5 and Host Conference Call on November 6 at 8:00 a.m. ET
a month ago - By: Aquestive Therapeutics, Inc.
Aquestive Therapeutics to Report Third Quarter 2025 Financial Results and Recent Business Highlights on November 5 and Host Conference Call on November 6 at 8:00 a.m. ET
2 months ago - By: Aquestive Therapeutics, Inc.
Aquestive Therapeutics Broadens Patent Estate for Anaphylm™
2 months ago - By: Aquestive Therapeutics, Inc.
Aquestive Therapeutics Broadens Patent Estate for Anaphylm™
3 months ago - By: Zacks Investment Research
- Mentions:
ADPT
ALLO
AKRO
AQST Stock Up as FDA Skips Advisory Meeting to Discuss Anaphylm NDA
3 months ago - By: Aquestive Therapeutics, Inc.
Aquestive Therapeutics Announces that FDA Will Not Require an Advisory Committee Meeting to Discuss New Drug Application for Anaphylm™
3 months ago - By: Aquestive Therapeutics, Inc.
Aquestive Therapeutics Announces that FDA Will Not Require an Advisory Committee Meeting to Discuss New Drug Application for Anaphylm™
3 months ago - By: Aquestive Therapeutics, Inc.
Aquestive Therapeutics to Participate in Upcoming September Investor Conferences
3 months ago - By: Aquestive Therapeutics, Inc.
Aquestive Therapeutics to Participate in Upcoming September Investor Conferences
4 months ago - By: Zacks Investment Research
- Mentions:
ABUS
Is Aquestive Therapeutics (AQST) Stock Outpacing Its Medical Peers This Year?
4 months ago - By: Aquestive Therapeutics, Inc.
Aquestive Therapeutics Announces Pricing of $85 Million Underwritten Offering of Common Stock
4 months ago - By: Aquestive Therapeutics, Inc.
Aquestive Therapeutics Announces Pricing of $85 Million Underwritten Offering of Common Stock
4 months ago - By: Aquestive Therapeutics, Inc.
Aquestive Therapeutics Announces $75M Strategic Funding Agreement with RTW to Support the Potential Launch of Anaphylm™ (epinephrine) Sublingual Film
4 months ago - By: Aquestive Therapeutics, Inc.
Aquestive Therapeutics Announces $75M Strategic Funding Agreement with RTW to Support the Potential Launch of Anaphylm™ (epinephrine) Sublingual Film
Please enable JavaScript to continue using this application.